SCHEMBL7328504

SCHEMBL7328504

CCOC(=O)CC(C)N1C(=O)c2cc(C#CCCCC#N)ccc2N(C(C)C)C(=O)C1c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 5/20 0.37
HDAC1 Q13547 5/20 0.34
HDAC6 Q9UBN7 4/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
PRKCA P17252 2/20 0.31
TP53 P04637 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7333749 0.93 MDM2 (0.36) MDM2HDAC1HDAC6HDAC3HDAC4
SCHEMBL7331704 0.92 HDAC1 (0.41) MDM2HDAC1HDAC6HDAC3HDAC4
SCHEMBL7335676 0.90 MDM2 (0.36) MDM2HDAC1HDAC6HDAC3HDAC4
SCHEMBL7329583 0.89 MDM2 (0.41) MDM2HDAC1HDAC6HDAC3HDAC4
SCHEMBL7330551 0.88 MDM2 (0.36) MDM2TP53KDM4EALDH1A1CYP1A2
SCHEMBL7330839 0.86 ADORA3 (0.34) MDM2HDAC1HDAC6HDAC3HDAC4
SCHEMBL7324864 0.86 KDM4E (0.32) MDM2TP53KDM4EALDH1A1CYP1A2
SCHEMBL7332372 0.83 HDAC1 (0.39) MDM2HDAC1HDAC6HDAC3HDAC4
SCHEMBL7323400 0.83 CASP3 (0.38) MDM2KDM4EALDH1A1
SCHEMBL7333805 0.82 MDM2 (0.35) MDM2HDAC1HDAC6HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663166-A ANTICOAGULANTS OF 1,4-BENZODIAZEPINE-2,5-DIONE AND 2-BENZOAZEPINE-1,4-DIONE DERIVATIVES; PREVENTS FIBRINOGEN BINDING NECESSARY FOR PLATELET AGGREGATION; SIDE EFFECT REDUCTION, E.G. EXCESSIVE BLEEDING GENENTECH, INC. (US) 1997-09-02 US disclosed
US-5565449-A PLATELET AGGREGATION INHIBITORS GENENTECH, INC. (US) 1996-10-15 US disclosed
EP-0610334-B1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII B III A RECEPTOR GENENTECH INC (US) 1996-01-24 EP disclosed
US-5403836-A Anticoagulants GENENTECH, INC. (US) 1995-04-04 US disclosed
EP-0610334-A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII b?III a? RECEPTOR. GENENTECH INC (US) 1994-08-17 EP disclosed
US-5250679-A Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor GENENTECH, INC. (US) 1993-10-05 US disclosed
WO-1993008174-A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPIIbIIIa RECEPTOR GENENTECH, INC. (US) 1993-04-29 WO disclosed